DETECTION AND RAPID CHARACTERIZATION OF COVID19 AND THE PATIENT
- Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
- Total publications:1 publications
Grant number: COV20_00279
Grant search
Key facts
Disease
COVID-19Funder
National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)Principal Investigator
FELIPE J CHAVES MARTÍNEZResearch Location
SpainLead Research Institution
FUNDACION PARA LA INVESTIGACION DE HOSPITAL CLINICO DE LA COMUNIDAD VALENCIANAResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The life cycle of coronaviruses allows differentiation between the encapsulated virus and its infection and replication processes. We will develop modular kits that allow, on the one hand, to determine the presence of the virus, the presence of viral processes involved in the infection and the determination of those variables that may be relevant in the development of the disease (viral and human). The kits will be based on isothermal amplification and rapid PCR of the regions of interest and their rapid detection (15-30 minutes the presence of the virus, available in 1 - 2 months). In a second kit-module, from these amplified and those of interest in relation to the patient, libraries will be generated to be sequenced using Nanopore systems. This second part of the study will make it possible to know the strain of the virus and the variables of the patient that are relevant in the disease, making a report based on the available data and including other clinical variables of interest.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC